LYRA - Lyra Therapeutics Inc.: New 52-Week Low Set Today (LYRA)
Shares of Lyra Therapeutics Inc. (NASDAQ:LYRA) traded today at $6.80, breaking its 52-week low. This new low was reached on approximately average trading volume as 133,000 shares traded hands, while the average 30-day volume is approximately 129,000 shares.
In the past 52 weeks, shares of Lyra Therapeutics Inc. have traded between the current low of $6.80 and a high of $16.50 and is now at $6.86.
Lyra Therapeutics Inc. (NASDAQ:LYRA) is currently priced 13.2% above its average consensus analyst price target of $5.95.
Lyra Therapeutics Inc a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company's technology platform, XTreo, is designed to precisely and consistently deliver medicines directly to the affected tissue for sustained periods with a single administration.
Receive IBN Spotlights - "Bite Size" Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer